Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.00
-1.00 (-2.08%)
Aug 12, 2025, 12:53 PM CST
-2.08%
Market Cap3.42B
Revenue (ttm)n/a
Net Income (ttm)-150.37M
Shares Out71.31M
EPS (ttm)-2.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,960
Average Volume49,154
Open48.00
Previous Close48.00
Day's Range47.00 - 48.10
52-Week Range34.30 - 72.80
Beta-0.06
RSI39.48
Earnings DateAug 11, 2025

About Paramount Global

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630 drug, for which is in Phase II clinical trial. It is also developing SNP-810 is in phase II clinical trial for use in Pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for acetamino... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.